Oxiglutatione in Advanced Melanoma Treatment
Advancements in cancer therapy have ushered in novel approaches for treating advanced melanoma. Keytruda, a checkpoint inhibitor, has emerged as a pivotal player. Its efficacy against this aggressive cancer form continues to garner attention. Unveiling the therapeutic landscape reveals intricate layers of immune responses and tumor biology. Understanding Keytruda’s Mechanism